Cargando…

The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo

INTRODUCTION: The viral 2A sequence has become an attractive alternative to the traditional internal ribosomal entry site (IRES) for simultaneous over-expression of two genes and in combination with recombinant adeno-associated viruses (rAAV) has been used to manipulate gene expression in vitro. NEW...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Jo E., Brameld, John M., Hill, Phil, Barrett, Perry, Ebling, Francis J.P., Jethwa, Preeti H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier/North-Holland Biomedical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659456/
https://www.ncbi.nlm.nih.gov/pubmed/26300182
http://dx.doi.org/10.1016/j.jneumeth.2015.08.013
_version_ 1782402628309745664
author Lewis, Jo E.
Brameld, John M.
Hill, Phil
Barrett, Perry
Ebling, Francis J.P.
Jethwa, Preeti H.
author_facet Lewis, Jo E.
Brameld, John M.
Hill, Phil
Barrett, Perry
Ebling, Francis J.P.
Jethwa, Preeti H.
author_sort Lewis, Jo E.
collection PubMed
description INTRODUCTION: The viral 2A sequence has become an attractive alternative to the traditional internal ribosomal entry site (IRES) for simultaneous over-expression of two genes and in combination with recombinant adeno-associated viruses (rAAV) has been used to manipulate gene expression in vitro. NEW METHOD: To develop a rAAV construct in combination with the viral 2A sequence to allow long-term over-expression of the vgf gene and fluorescent marker gene for tracking of the transfected neurones in vivo. RESULTS: Transient transfection of the AAV plasmid containing the vgf gene, viral 2A sequence and eGFP into SH-SY5Y cells resulted in eGFP fluorescence comparable to a commercially available reporter construct. This increase in fluorescent cells was accompanied by an increase in VGF mRNA expression. Infusion of the rAAV vector containing the vgf gene, viral 2A sequence and eGFP resulted in eGFP fluorescence in the hypothalamus of both mice and Siberian hamsters, 32 weeks post infusion. In situ hybridisation confirmed that the location of VGF mRNA expression in the hypothalamus corresponded to the eGFP pattern of fluorescence. COMPARISON WITH OLD METHOD: The viral 2A sequence is much smaller than the traditional IRES and therefore allowed over-expression of the vgf gene with fluorescent tracking without compromising viral capacity. CONCLUSION: The use of the viral 2A sequence in the AAV plasmid allowed the simultaneous expression of both genes in vitro. When used in combination with rAAV it resulted in long-term over-expression of both genes at equivalent locations in the hypothalamus of both Siberian hamsters and mice, without any adverse effects.
format Online
Article
Text
id pubmed-4659456
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier/North-Holland Biomedical Press
record_format MEDLINE/PubMed
spelling pubmed-46594562015-12-30 The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo Lewis, Jo E. Brameld, John M. Hill, Phil Barrett, Perry Ebling, Francis J.P. Jethwa, Preeti H. J Neurosci Methods Basic Neuroscience INTRODUCTION: The viral 2A sequence has become an attractive alternative to the traditional internal ribosomal entry site (IRES) for simultaneous over-expression of two genes and in combination with recombinant adeno-associated viruses (rAAV) has been used to manipulate gene expression in vitro. NEW METHOD: To develop a rAAV construct in combination with the viral 2A sequence to allow long-term over-expression of the vgf gene and fluorescent marker gene for tracking of the transfected neurones in vivo. RESULTS: Transient transfection of the AAV plasmid containing the vgf gene, viral 2A sequence and eGFP into SH-SY5Y cells resulted in eGFP fluorescence comparable to a commercially available reporter construct. This increase in fluorescent cells was accompanied by an increase in VGF mRNA expression. Infusion of the rAAV vector containing the vgf gene, viral 2A sequence and eGFP resulted in eGFP fluorescence in the hypothalamus of both mice and Siberian hamsters, 32 weeks post infusion. In situ hybridisation confirmed that the location of VGF mRNA expression in the hypothalamus corresponded to the eGFP pattern of fluorescence. COMPARISON WITH OLD METHOD: The viral 2A sequence is much smaller than the traditional IRES and therefore allowed over-expression of the vgf gene with fluorescent tracking without compromising viral capacity. CONCLUSION: The use of the viral 2A sequence in the AAV plasmid allowed the simultaneous expression of both genes in vitro. When used in combination with rAAV it resulted in long-term over-expression of both genes at equivalent locations in the hypothalamus of both Siberian hamsters and mice, without any adverse effects. Elsevier/North-Holland Biomedical Press 2015-12-30 /pmc/articles/PMC4659456/ /pubmed/26300182 http://dx.doi.org/10.1016/j.jneumeth.2015.08.013 Text en © 2015 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Basic Neuroscience
Lewis, Jo E.
Brameld, John M.
Hill, Phil
Barrett, Perry
Ebling, Francis J.P.
Jethwa, Preeti H.
The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
title The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
title_full The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
title_fullStr The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
title_full_unstemmed The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
title_short The use of a viral 2A sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (eGFP) in vitro and in vivo
title_sort use of a viral 2a sequence for the simultaneous over-expression of both the vgf gene and enhanced green fluorescent protein (egfp) in vitro and in vivo
topic Basic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659456/
https://www.ncbi.nlm.nih.gov/pubmed/26300182
http://dx.doi.org/10.1016/j.jneumeth.2015.08.013
work_keys_str_mv AT lewisjoe theuseofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT brameldjohnm theuseofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT hillphil theuseofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT barrettperry theuseofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT eblingfrancisjp theuseofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT jethwapreetih theuseofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT lewisjoe useofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT brameldjohnm useofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT hillphil useofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT barrettperry useofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT eblingfrancisjp useofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo
AT jethwapreetih useofaviral2asequenceforthesimultaneousoverexpressionofboththevgfgeneandenhancedgreenfluorescentproteinegfpinvitroandinvivo